The exact drivers in the growth of therapeutic pain management services are chronic back pain and cancer treatments. The combination of high-volume demand for services and effective treatment options combined with favorable government healthcare policies will generate a CAGR of 4% globally and an estimated $88 billion-dollar valuation by 2025.
Prevalence of chronic pain management needs and expected growth influence the high valuations domestically and internationally over the next six years.